Breakthrough Treatment Achieves 100% Survival in Aggressive Inherited Breast Cancers, Cambridge Researchers Announce
Billy Candra Cambridge researchers have unveiled a groundbreaking new treatment approach that has demonstrably improved survival rates...
Breast Cancer: Research & Awareness
Revolutionary Ultra-Rapid Genetic Diagnosis for Brain Tumours Slashes Wait Times from Weeks to Hours, Transforming Patient Care Across the UK
Scientists and clinicians at the University of Nottingham and Nottingham University Hospitals NHS Trust (NUH)...
Genetics and therapy type determine second cancer risk after childhood treatment
Physicians dedicated to the lifelong care of childhood cancer survivors must now integrate a deeper...
Unlocking New Hope: Keck Medicine Researchers Discover Potent Combination Therapy Significantly Extends Survival for Glioblastoma Patients
A groundbreaking study spearheaded by researchers at Keck Medicine of USC has unveiled a potentially...
Combining Two Advanced Cancer Therapies Substantially Slows Progression of Aggressive Prostate Cancer in Men with Specific Genetic Mutations
A groundbreaking international study spearheaded by researchers at University College London (UCL) has unveiled a...
Scientists find 15 gut bacteria that may drive heart disease
Cardiovascular diseases (CVDs) tragically claim nearly 20 million lives each year, establishing themselves as the...
Scientists discover how to wipe out breast cancer’s hidden cells
This groundbreaking research, spearheaded by scientists at the Abramson Cancer Center of the University of...
A Paradigm Shift in Breast Cancer Screening: Personalized Risk Assessment Proves More Effective and Safer Than Universal Annual Mammograms
The landscape of breast cancer screening is poised for a significant transformation, as a groundbreaking...
Unmasking the Dual Nature of Regulatory T Cells: A Breakthrough in Colorectal Cancer Immunotherapy
In a significant advance for cancer research, scientists at the Sloan Kettering Institute (SKI) at...
Combination of Niraparib and Abiraterone Significantly Delays Progression in Advanced Prostate Cancer Patients with Specific Genetic Mutations.
A landmark international study spearheaded by researchers at University College London (UCL) has unveiled a...
